Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients

Paungpaga Lertdumrongluk, Connie M. Rhee, Jongha Park, Wei Ling Lau, Hamid Moradi, Jennie Jing, Miklos Z. Molnar, Steven M. Brunelli, Allen R. Nissenson, Csaba P. Kovesdy, Kamyar Kalantar-Zadeh

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Objective: Hypo- and hyperphosphatemia have each been associated with increased mortality in maintenance hemodialysis (MHD) patients. There has not been previous evaluation of a differential relationship between serum phosphorus level and death risk across varying age groups in MHD patients. Design and Settings: In a 6-year cohort of 107,817 MHD patients treated in a large dialysis organization, we examined the association between serum phosphorus levels with all-cause and cardiovascular mortality within 5 age categories (15 to <45, 45 to <65, 65 to <70, 70 to <75, and ≥75 years old) using Cox proportional hazards models adjusted for case-mix covariates and malnutrition inflammation complex syndrome (MICS) surrogates. Main Outcome Measure: All-cause and cardiovascular mortality. Results: The overall mean age of the cohort was 60 ± 16 years, among whom there were 45% women, 35% Blacks, and 58% diabetics. The time-averaged serum phosphorus level (mean±SD) within each age category was 6.26 ± 1.4, 5.65 ± 1.2, 5.26 ± 1.1, 5.11 ± 1.0, and 4.88 ± 1.0 mg/dL, respectively (P for trend <.001). Hyperphosphatemia (>5.5 mg/dL) was consistently associated with increased all-cause and cardiovascular mortality risks across all age categories, including after adjustment for case-mix and MICS-related covariates. In fully adjusted models, a low serum phosphorus level (<3.5 mg/dL) was associated with increased all-cause mortality only in elderly MHD patients ≥65 years old (hazard ratio [95% confidence interval]: 1.21 [1.07-1.37], 1.13 [1.02-1.25], and 1.28 [1.2-1.37] for patients 65 to <70, 70 to <75, and ≥75 years old, respectively), but not in younger patients (<65 years old). A similar differential cardiovascular mortality risk for low serum phosphorus levels between old and young age groups was observed. Conclusions: The association between hyperphosphatemia and mortality is similar across all age groups of MHD patients, whereas hypophosphatemia is associated with increased mortality only in elderly MHD patients. Preventing very low serum phosphorus levels in elderly dialysis patients may be associated with better outcomes, which needs to be examined in future studies.

Original languageEnglish
Pages (from-to)411-421
Number of pages11
JournalJournal of Renal Nutrition
Volume23
Issue number6
DOIs
Publication statusPublished - Nov 2013

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Nephrology

Fingerprint Dive into the research topics of 'Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients'. Together they form a unique fingerprint.

  • Cite this

    Lertdumrongluk, P., Rhee, C. M., Park, J., Lau, W. L., Moradi, H., Jing, J., Molnar, M. Z., Brunelli, S. M., Nissenson, A. R., Kovesdy, C. P., & Kalantar-Zadeh, K. (2013). Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients. Journal of Renal Nutrition, 23(6), 411-421. https://doi.org/10.1053/j.jrn.2013.01.018